Labcorp Holdings Inc. (LH)
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
LH stock chart
Technical analysisKey statistics
All statistics- Market cap
- $29.81B
- P/E (TTM)
- 30.09
- Forward P/E
- 18.73
- EPS (TTM)
- $12.20
- Dividend yield
- 0.78% ($2.88)
- Ex-dividend date
- Aug 28, 2026
- 52-week range
- 245.00 – 375.10
- Day range
- 366.38 – 372.21
- Volume / Avg
- 890.42K / 744.44K
- Beta
- —
- Shares outstanding
- 81.20M
52-week range
LH stock today
Labcorp (LH) closed at $367.13 on Nov 20, down 0.47% (-$1.75), versus the S&P 500's 3.70% decline. At this level, LH sits near the top of its 52-week range of $245.00 to $375.10: 2.1% below the high, set on Nov 12, 2026 and 49.8% above the low. LH is up 46.3% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 38.2%.
At 30.1x trailing earnings, Labcorp trades above the peer-group median of 25.7x. Its forward P/E of 18.7x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Labcorp pays an annual dividend of $2.88 per share, a 0.78% yield at the current price.
Summary generated from market data by MetaCap's automated system. Methodology
About Labcorp
Company profileLabcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Adam H. Schechter
- Headquarters
- Burlington, NC
- Employees
- 71,000
- Website
- labcorp.com
Financial highlights
Full financialsIn fiscal 2025, Labcorp generated $13.95 billion in revenue, up 7.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $876.5 million (+17.5% year over year), for a net margin of 6.3% versus a median of 10.8% in the prior 5 years. Gross margin was 28.8% (up from 27.9%) and operating margin 9.9%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $13.95B | $13.01B | $12.16B | $11.86B | $13.14B |
| Growth | +7.25% | +6.97% | +2.51% | -9.68% | -6.03% |
| Net income | $876.50M | $746.00M | $418.00M | $1.28B | $2.38B |
| EPS (diluted) | $10.46 | $8.84 | $4.77 | $13.97 | $24.39 |
Analyst forecast
ForecastConsensus (17 analysts)
buy
Avg. price target
$390.06+6.25%
- Strong buy 2
- Buy 11
- Hold 4
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Oct 28, 2026
- EPS actual vs est.
- $4.18 vs $4.65
- Surprise
- -10.11%
Dividends
Dividend history- Annual dividend
- $2.88
- Dividend yield
- 0.78%
- Last payment
- $0.72
- Ex-dividend date
- Aug 28, 2026
LH news
All LH news- Labcorp to Expand Clinical Trial Operations in Brazil with Dedicated Kit Assembly and Future Laboratory Operations through Collaboration with Grupo FleuryPR Newswire
- Why Labcorp Holdings (LH) is a Top Value Stock for the Long-TermNasdaq
- OPKO Slips To Loss In Q3 On Impact Of Discontinued Operations, Revenue UpNasdaqLH, LLY, OPK, MKC.V
- Labcorp’s Lab Growth Surges as $125 Million Reimbursement Risk LoomsNasdaq
- Labcorp: 3 Key Takeaways for Long-Term InvestorsNasdaq
- Labcorp Holdings Inc. (LH) Presents at 2026 UBS Global Healthcare Conference TranscriptSeeking Alpha
- Is Now the Right Time to Hold Labcorp Stock in Your Portfolio?NasdaqLH, IDXX, GMED, PAHC
- Labcorp raised to Buy at HSBC on M&A and diagnostics momentumSeeking AlphaLH, HSBC
Labcorp peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ILMNIllumina Inc. | 192.82 | -3.90% | $29.15B | vs LH |
| DGXQuest Diagnostics Incorporated | 258.28 | -0.31% | $28.42B | vs LH |
| CNCCentene Corporation | 63.78 | -2.74% | $31.58B | vs LH |
| NTRANatera Inc. | 273.40 | -5.70% | $39.64B | vs LH |
| GHGuardant Health Inc. | 145.83 | +0.16% | $19.73B | vs LH |
| HUMHumana Inc. | 390.00 | +2.63% | $46.84B | vs LH |
| MOHMolina Healthcare Inc | 198.39 | -2.43% | $10.36B | vs LH |
| HSICHenry Schein Inc. | 83.52 | -1.51% | $9.23B | vs LH |
Indexes, lists and sector
Labcorp stock FAQ
What is Labcorp's stock price today?
LH last traded at $367.13 as of Nov 20, 4:00 PM EST, down 0.47% on the day. Prices are delayed at least 15 minutes.
Does Labcorp pay a dividend?
Yes. Labcorp pays $2.88 per share annually, a 0.78% yield. The most recent dividend of $0.72 had an ex-dividend date of Aug 28, 2026.
What is LH's P/E ratio?
LH trades at a trailing P/E ratio of 30.09 and a forward P/E of 18.73, compared with a median of 25.7 for its closest peers.
Is Labcorp in the S&P 500?
Yes. Labcorp (LH) is a constituent of the S&P 500 index.
Who is Labcorp's CEO?
Mr. Adam H. Schechter is the chief executive officer of Labcorp Holdings Inc., which has about 71,000 employees.
Has LH ever split its stock?
Yes. The most recent LH stock split was a 1164-for-1000 split on Jul 3, 2023, one of 4 splits on record.
What is the LH 52-week high?
The 52-week high for LH is $375.10 and the 52-week low is $245.00. The stock is currently 2.1% below its high.